Related Experiment Video
Updated: May 20, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
ABO chimerism determined by real-time polymerase chain reaction analysis after ABO-incompatible haematopoietic stem
Feng Liu1, Guining Li, Xiaolu Mao
1Department of Blood Transfusion, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Background:
The dynamic alteration of ABO blood group in ABO-incompatible haematopoietic stem cell transplantation can be well defined by ABO chimerism analysis. In view of the intrinsic difference in ABO phenotypes or genotypes between donor and recipient in ABO incompatible transplantation, ABO allele-associated nucleotide polymorphic sites could theoretically be used as available informative markers for chimerism analysis.
Materials And Methods:
We chose nucleotide polymorphism sites (261, 467, 802, 803 and 1,061) of common ABO alleles to use as markers from 76 randomly chosen donors and assessed the limit of linear detection of a specifically designed real-time quantitative polymerase chain reaction using SYBR Green I dye with these sites for a chimerism assay.
Results:
We successfully established the real-time quantitative polymerase chain reaction for detecting 261, 467(mutated) and 803 sites and their limits of linear detection, which were at least 10(-3), 10(-2) and 10(-2), respectively. The limits of linear detection between heterozygous DNA and homozygous DNA with 261 or 803 sites were not significantly different.
Discussion:
ABO chimerism can be well analysed by real-time polymerase chain reaction with ABO gene-associated nucleotide polymorphic sites. This strategy could be very beneficial for the early and accurate judgement of the crucial point of transition in order to plan a safe transfusion strategy following ABO-incompatible transplantation.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...

